{"entity":{"type":"insider","cik":"0001954186","url":"/insider/0001954186","json_url":"/insider/0001954186.json","name":"Nikolaou Anastasis","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2022-11-21","last":"2023-06-28","span_basis":"filed_date"},"name_variants":[{"name":"Nikolaou Anastasis","source":"filing","n_filings":4,"first_seen":"2022-11-21","last_seen":"2023-06-28"}],"transactions":[{"id":8079937,"accession":"0001213900-23-052442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-052442","line_url":"/filing/0001213900-23-052442#line-1","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis","owner_display_name":"Chione Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16.0,"shares_display":"16","price_per_share":12.93,"price_display":"12.93","price_state":"stated","total_value":206.88,"total_display":"206.88","total_whole":"207","shares_owned_after":3848632.0,"shares_owned_after_display":"3,848,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-28","scope":"insider"},{"id":8117836,"accession":"0001213900-23-050160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-050160","line_url":"/filing/0001213900-23-050160#line-1","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Czernik Marcin; Nikolaou Anastasis","owner_display_name":"Chione Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2056.0,"shares_display":"2,056","price_per_share":12.14,"price_display":"12.14","price_state":"stated","total_value":24959.84,"total_display":"24,959.84","total_whole":"24,960","shares_owned_after":3848648.0,"shares_owned_after_display":"3,848,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":8585857,"accession":"0001213900-23-049014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-049014","line_url":"/filing/0001213900-23-049014#line-3","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas","owner_display_name":"Chione Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":893.0,"shares_display":"893","price_per_share":12.13,"price_display":"12.13","price_state":"stated","total_value":10832.09,"total_display":"10,832.09","total_whole":"10,832","shares_owned_after":3850704.0,"shares_owned_after_display":"3,850,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-14","scope":"insider"},{"id":8585855,"accession":"0001213900-23-049014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-049014","line_url":"/filing/0001213900-23-049014#line-2","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas","owner_display_name":"Chione Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.3,"price_display":"12.30","price_state":"stated","total_value":36900.0,"total_display":"36,900.00","total_whole":"36,900","shares_owned_after":3851597.0,"shares_owned_after_display":"3,851,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":8585853,"accession":"0001213900-23-049014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-049014","line_url":"/filing/0001213900-23-049014#line-1","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas","owner_display_name":"Chione Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.34,"price_display":"12.34","price_state":"stated","total_value":24680.0,"total_display":"24,680.00","total_whole":"24,680","shares_owned_after":3854597.0,"shares_owned_after_display":"3,854,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":6736181,"accession":"0001213900-22-074313","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-22-074313","line_url":"/filing/0001213900-22-074313#line-3","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_display_name":"Chione Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3856597.0,"shares_owned_after_display":"3,856,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001781174","name":"Acrivon Therapeutics, Inc.","url":"/issuer/0001781174","role":"Ten percent owner","n_filings":4,"first_seen":"2022-11-21","last_seen":"2023-06-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001954186","retrieved_at":"2026-08-25T19:49:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}